Prescription medicine
Purpose & Usage : Development of prescription medicines for the prevention and treatment of influenza virus infections
1. Prevention and treatment for influenza A and B infection.
2. Treatment against viral infections with NA-inhibitor-resistant viruses.
3. Treatment for patients infected with severe influenza after vaccination

Non-prescription medicine
Purpose & Usage : NVG308 can be developed as non-prescription medicine in several countries
complying with each nation's FDA guideline by utilizing pre-clinical and clinical data or if required, post-marketing data for safety and efficacy(phase 4 clinical trial)

Quasi drug
Purpose & Usage : Production of NVG308 as industrial enzyme by optimization
Potential as a nucleic acid hydrolyzer
- Nucleic acids should be eliminated from the Living Modified Organism(LMO) products thoroughly according to EU regulations(scheduled revision in 2019) on LMOs
- We can create new market opportunities for nucleic acid hydrolyzing enzymes by presenting domestic and global standard

Prescription medicine, Non-prescription medicine, Preventive goods
Purpose and Usage : Development as medicine and goods for the prevention and the treatment of animal influenza viruses
- Wild Birds, Poultry: Avian Influenza (H5N1, H7N9, H5N6)
- Livestock: Swine Influenza (H1N1), Porcine Epidemic Diarrhea (PED), African Swine Fever Virus (ASFV), Equine Influenza (H7N7, H3N8)
- Companion animal: Canine Influenza (H3N8), Cat Influenza (H1N1)

Functional feed or feed supplements
Purpose & Usage : By building a mass production system for innovative antibody NVG308
1) Functional fee with antiviral activities
2) Feed supplements or additives with antiviral activities